Intercure(INCR.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Intercure
INCR.US
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd.
4.675 T
INCR.USMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking96/190
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-9.00%D
    • Profit Margin-13.22%D
    • Gross Margin15.06%D
  • Growth ScoreB
    • Revenue YoY24.17%A
    • Net Profit YoY42.18%B
    • Total Assets YoY3.83%C
    • Net Assets YoY14.28%B
  • Cash ScoreC
    • Cash Flow Margin-47.16%E
    • OCF YoY24.17%A
  • Operating ScoreC
    • Turnover0.37C
  • Debt ScoreC
    • Gearing Ratio42.60%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow | INCR Stock News

    StockTitan·
    US
    INCR
    +3.65%
    StockTitan·
    US
    INCR
    +3.65%

    Extendicare Sets Date for Q1 2026 Results and Investor Call

    Tip Ranks·
    US
    ICCM
    +3.64%
    US
    IHI
    +1.00%
    US
    INCR
    +3.65%
    Tip Ranks·
    US
    ICCM
    +3.64%
    US
    IHI
    +1.00%
    US
    INCR
    +3.65%

    Photocure leverages EAU 2026 trials to cement role in precision bladder cancer care

    Tip Ranks·
    US
    INCR
    +3.65%
    US
    ICCM
    +3.64%
    US
    CUBT
    -1.84%
    Tip Ranks·
    US
    INCR
    +3.65%
    US
    ICCM
    +3.64%
    US
    CUBT
    -1.84%

    InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement | INCR Stock News

    StockTitan·
    US
    INCR
    +3.65%
    StockTitan·
    US
    INCR
    +3.65%

    InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans

    Tip Ranks·
    US
    INCR
    +3.65%
    Tip Ranks·
    US
    INCR
    +3.65%
    © 2026 Longbridge｜Disclaimer